Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01848067
What this trial is testing

Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Large-scale testing (Phase 3)Study completedNCT00033631
What this trial is testing

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,534
Not applicableActive Not RecruitingNCT04624256
What this trial is testing

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 208
Testing effectiveness (Phase 2)Study completedNCT00258388
What this trial is testing

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT03624660
What this trial is testing

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
University of Florida 100
Testing effectiveness (Phase 2)Study completedNCT01174368
What this trial is testing

Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T

Who this might be right for
Prostate Cancer
The Rogosin Institute 1
Testing effectiveness (Phase 2)UnknownNCT00003717
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
St. Barnabas Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT00078585
What this trial is testing

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Bavarian Nordic 120
Large-scale testing (Phase 3)Study completedNCT00004124
What this trial is testing

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 983
Testing effectiveness (Phase 2)Study completedNCT00554918
What this trial is testing

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
University Hospital Birmingham 300
Testing effectiveness (Phase 2)Study completedNCT00087035
What this trial is testing

Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 1
Not applicableStudy completedNCT00084552
What this trial is testing

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate CancerSexual DysfunctionSexuality and Reproductive Issues
Fox Chase Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT01498978
What this trial is testing

Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
OHSU Knight Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00005820
What this trial is testing

Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 35
Large-scale testing (Phase 3)Study completedNCT00331773
What this trial is testing

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,116
Not applicableLooking for participantsNCT07468903
What this trial is testing

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8
Jonsson Comprehensive Cancer Center 45
Large-scale testing (Phase 3)Study completedNCT00869206
What this trial is testing

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Who this might be right for
Breast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell Myeloma+4 more
Alliance for Clinical Trials in Oncology 1,822
Testing effectiveness (Phase 2)Study completedNCT00499408
What this trial is testing

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 26
Testing effectiveness (Phase 2)Study completedNCT00309894
What this trial is testing

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 49
Testing effectiveness (Phase 2)Study completedNCT00561314
What this trial is testing

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate CancerSexual DysfunctionUrinary Incontinence
University College London Hospitals 33
Next Page